Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19
Clinical trial NCT05279391 · UNKNOWN
Trial details
- NCT number
- NCT05279391
- Sponsor
- Democritus University of Thrace
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-25
- Primary completion
- 2021-11-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.